Samsung in Talks to Buy Alzheimer's Drug Maker for $42 Billion: Report

Biogen shares surged following a report that Samsung is in talks to acquire the US biotech company for more than $40 billion (roughly Rs. 2,98,170 crore).

from NDTV Gadgets - Latest https://ift.tt/3Jtfszt

Comments

Popular posts from this blog

Younger Generations of Traders Favour AI Advancements in Crypto, Web3 Sector: KuCoin Report

From Animal, Sam Bahadur to Griselda: Here Are the Top OTT Releases of This Week to Binge-Watch This Weekend

3Commas Tweaks Internal Security After Accounts of Some Users Were Compromised, Passwords Reset